Central nervous system — the brain and spinal cord Peripheral nervous system — the nerves that make your muscles move and tell your brain what your body is feeling Autonomic nervous system — the ...
Our most recent episode of The Expert Series podcast explores the newly released SLE treatment guidelines and how they might affect patient care.
Techno-Science.net on MSN
Lupus: Discovery of markers to identify patients at highest risk
An international team, led by Paul R. Fortin of Université Laval, has just identified three markers that would allow for establishing, right at the time of diagnosis, the risk of a lupus ...
In patients with systemic lupus erythematosus, impaired upper limb function and difficulty performing daily activities are linked to various quality-of-life domains.
Credit: Getty Images Understanding the underlying mechanisms and immunological dysfunction of SLE is essential to appreciate its diverse clinical manifestations and guide effective diagnosis and ...
Systemic Lupus Erythematosus is one of the most complex autoimmune diseases seen in modern medicine, affecting multiple organs and presenting differently from one patient to another. Often referred to ...
CNW/ - Hoffmann-La Roche Limited (Roche Canada) is pleased to announce that on January 22, 2026, Health Canada has approved Gazyva® (obinutuzumab) for ...
How would you treat a 30-year-old woman with systemic lupus erythematous (SLE) and lupus nephritis (LN) class 3 with new ...
NICE has recommended obinutuzumab with mycophenolate for severe lupus nephritis after trials showed higher renal response and fewer flares.
Flow Space on MSN
The silent burden of lupus flares: How to advocate for yourself when symptoms don't add up
You still have options.
The total market size of systemic lupus erythematosus is expected to increase in the 7MM during the forecast period, driven by ongoing clinical research of therapies such as nipocalimab (Johnson & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results